免疫检查点抑制剂与免疫相关不良事件。 - Suppr

Suppr

超能文献

Immune checkpoint inhibitors and immune-related adverse events.

作者信息

Naidoo Winston, Cuff Katharine, Ryan Marissa

机构信息

Pharmacy Department, Princess Alexandra Hospital, Brisbane.

Division of Cancer Services, Princess Alexandra Hospital, Brisbane.

出版信息

Aust Prescr. 2024 Oct;47(5):153-155. doi: 10.18773/austprescr.2024.039.

DOI:10.18773/austprescr.2024.039

PMID:39526080

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11540909/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6de4/11540909/57a0312e69f5/austprescr-47-153-f1.jpg

相似文献

Immune checkpoint inhibitors and immune-related adverse events.免疫检查点抑制剂与免疫相关不良事件。

Aust Prescr. 2024 Oct;47(5):153-155. doi: 10.18773/austprescr.2024.039.

Optimal management of immune-related adverse events resulting from treatment with immune checkpoint inhibitors: a review and update.免疫检查点抑制剂治疗相关免疫相关不良事件的最佳管理：综述与更新。

Int J Clin Oncol. 2018 Jun;23(3):410-420. doi: 10.1007/s10147-018-1259-6. Epub 2018 Mar 7.

Knowledge domains and emerging trends in immune-related adverse events from immune checkpoint inhibitors: A bibliometrics and visualized analysis.免疫检查点抑制剂相关免疫不良反应的知识领域与新兴趋势：一项文献计量学与可视化分析

Heliyon. 2024 Mar 13;10(6):e27832. doi: 10.1016/j.heliyon.2024.e27832. eCollection 2024 Mar 30.

Real-world safety experience with immune checkpoint inhibitors in Saudi Arabia.沙特阿拉伯免疫检查点抑制剂的真实世界安全性经验。

Sci Prog. 2021 Jan-Mar;104(1):36850421997302. doi: 10.1177/0036850421997302.

Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study.免疫检查点抑制剂引起的多器官免疫相关不良事件及其下游影响：一项回顾性多队列研究。

Lancet Oncol. 2024 Aug;25(8):1053-1069. doi: 10.1016/S1470-2045(24)00278-X. Epub 2024 Jul 15.

Characteristics of hospitalizations among patients receiving immune checkpoint inhibitors at a community teaching hospital.一家社区教学医院中接受免疫检查点抑制剂治疗患者的住院特征。

J Oncol Pharm Pract. 2020 Jan;26(1):60-66. doi: 10.1177/1078155219836155. Epub 2019 Mar 29.

The correlation between immune-related adverse events and efficacy of immune checkpoint inhibitors.免疫相关不良反应与免疫检查点抑制剂疗效的相关性。

Jpn J Clin Oncol. 2024 Sep 4;54(9):949-958. doi: 10.1093/jjco/hyae067.

Front Immunol. 2023 May 25;14:1167975. doi: 10.3389/fimmu.2023.1167975. eCollection 2023.

[Advances in Predictive Research of Immune Checkpoint Inhibitors-related  Adverse Events].[免疫检查点抑制剂相关不良事件的预测性研究进展]

Zhongguo Fei Ai Za Zhi. 2023 Oct 20;26(10):789-794. doi: 10.3779/j.issn.1009-3419.2023.106.20.

Immune checkpoint inhibitors and cancer immunotherapy by aptamers: an overview.免疫检查点抑制剂和适体的癌症免疫治疗：概述。

Med Oncol. 2023 Dec 29;41(1):40. doi: 10.1007/s12032-023-02267-4.

本文引用的文献

Aust J Gen Pract. 2023 Jun;52(6):378-385. doi: 10.31128/AJGP-04-22-6408.

Persistent immune-related adverse events after cessation of checkpoint inhibitor therapy: Prevalence and impact on patients' health-related quality of life.检查点抑制剂治疗停止后持续存在的免疫相关不良事件：患病率及其对患者健康相关生活质量的影响。

Eur J Cancer. 2022 Nov;176:88-99. doi: 10.1016/j.ejca.2022.08.029. Epub 2022 Oct 2.

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.免疫检查点抑制剂治疗患者免疫相关不良反应的管理：ASCO 指南更新。

J Clin Oncol. 2021 Dec 20;39(36):4073-4126. doi: 10.1200/JCO.21.01440. Epub 2021 Nov 1.

Two cases of delayed onset of immune-related adverse events after discontinuation of nivolumab in patients with metastatic renal cell cancer.两例转移性肾细胞癌患者停用纳武利尤单抗后出现免疫相关不良事件延迟发作的病例。

IJU Case Rep. 2021 Jun 28;4(5):326-329. doi: 10.1002/iju5.12338. eCollection 2021 Sep.

Delayed immune-related adverse events with anti-PD-1-based immunotherapy in melanoma.黑色素瘤中基于抗PD-1免疫疗法的延迟性免疫相关不良事件。

Ann Oncol. 2021 Jul;32(7):917-925. doi: 10.1016/j.annonc.2021.03.204. Epub 2021 Mar 30.

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.免疫检查点抑制剂的不良反应：流行病学、管理和监测。

Nat Rev Clin Oncol. 2019 Sep;16(9):563-580. doi: 10.1038/s41571-019-0218-0.

Immune checkpoint inhibitors in malignancy.恶性肿瘤中的免疫检查点抑制剂。

Aust Prescr. 2019 Apr;42(2):62-67. doi: 10.18773/austprescr.2019.012. Epub 2019 Apr 1.

Adverse events associated with immune checkpoint inhibitor treatment for cancer.与癌症免疫检查点抑制剂治疗相关的不良事件。

CMAJ. 2019 Jan 14;191(2):E40-E46. doi: 10.1503/cmaj.180870.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验